Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Clinical Therapeutics|August 25, 2009
Trends in prescriptions for antidepressant pharmacotherapy among US children and adolescents diagnosed with depression, 1990 through 2001: an assessment of accordance with treatment recommendations from the American Academy of Child and Adolescent PsychiatryTracy L Skaer, David A Sclar, Linda M Robison
Headache|November 17, 2007
Concomitant triptan and SSRI or SNRI use: a risk for serotonin syndromeDavid A Sclar, Linda M Robison, Tracy L Skaer
General Hospital Psychiatry|January 1, 2008
Hospital length of stay for children and adolescents diagnosed with depression: is primary payer an influencing factor?David A Sclar, Linda M Robison, Corrine Gavrun, et al.
International Clinical Psychopharmacology|April 23, 2004
Treatment modalities among US children diagnosed with attention-deficit hyperactivity disorder: 1995-99Linda M Robison, David A Sclar, Tracy L Skaer, et al.
CNS Drugs|February 5, 2002
Is attention deficit hyperactivity disorder increasing among girls in the US? Trends in diagnosis and the prescribing of stimulantsLinda M Robison, Tracy L Skaer, David A Sclar, et al.
Clinical Drug Investigation|April 7, 2012
α1-Proteinase inhibitor (human) in the treatment of hereditary emphysema secondary to α1-antitrypsin deficiency: number and costs of years of life gainedDavid Alexander Sclar, Marc A Evans, Linda M Robison, et al.
Current Therapeutic Research, Clinical and Experimental|April 3, 2014
Prevalence of depression and use of antidepressant pharmacotherapy among ambulatory patients with diabetes mellitus in the United StatesJoshua J Neumiller, David A Sclar, Linda M Robison, et al.
Primary Care Diabetes|August 4, 2009
Rate of obesity in U.S. ambulatory patients with diabetes mellitus: a national assessment of office-based physician visitsJoshua J Neumiller, David A Sclar, Linda M Robison, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|March 26, 2010
Ethnicity/race, use of pharmacotherapy, scope of physician-ordered cholesterol screening, and provision of diet/nutrition or exercise counseling during US office-based visits by patients with hyperlipidemiaMegan N Willson, Joshua J Neumiller, David A Sclar, et al.
Drugs in R&D|May 5, 2005
Economic and epidemiological modelling of full-length antihaemophilic factor (recombinant), plasma/albumin-free method, in previously treated patients with haemophilia A : comparison with B-domain deleted rFVIII, and value of potential viral transmission reduction due to plasma/albumin-free statusDavid A Sclar, Marc A Evans, Tracy L Skaer, et al.
Pageof 3